Example of Annals of the Rheumatic Diseases format
Recent searches

Example of Annals of the Rheumatic Diseases format Example of Annals of the Rheumatic Diseases format Example of Annals of the Rheumatic Diseases format Example of Annals of the Rheumatic Diseases format Example of Annals of the Rheumatic Diseases format Example of Annals of the Rheumatic Diseases format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Annals of the Rheumatic Diseases format Example of Annals of the Rheumatic Diseases format Example of Annals of the Rheumatic Diseases format Example of Annals of the Rheumatic Diseases format Example of Annals of the Rheumatic Diseases format Example of Annals of the Rheumatic Diseases format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access
recommended Recommended

Annals of the Rheumatic Diseases — Template for authors

Categories Rank Trend in last 3 yrs
Rheumatology #1 of 56 -
Biochemistry, Genetics and Molecular Biology (all) #3 of 204 up up by 1 rank
Immunology #4 of 202 up up by 1 rank
Immunology and Allergy #4 of 182 up up by 1 rank
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 845 Published Papers | 24277 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 09/06/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

Springer

Quality:  
Good
CiteRatio: 4.0
SJR: 0.806
SNIP: 1.015
open access Open Access

Taylor and Francis

Quality:  
High
CiteRatio: 8.4
SJR: 2.078
SNIP: 1.475
open access Open Access
recommended Recommended

Nature

Quality:  
High
CiteRatio: 53.9
SJR: 20.529
SNIP: 8.97
open access Open Access

Frontiers Media

Quality:  
High
CiteRatio: 8.1
SJR: 2.646
SNIP: 1.573

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

16.102

13% from 2018

Impact factor for Annals of the Rheumatic Diseases from 2016 - 2019
Year Value
2019 16.102
2018 14.299
2017 12.35
2016 12.811
graph view Graph view
table view Table view

28.7

11% from 2019

CiteRatio for Annals of the Rheumatic Diseases from 2016 - 2020
Year Value
2020 28.7
2019 25.9
2018 24.1
2017 24.1
2016 22.0
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has increased by 13% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • CiteRatio of this journal has increased by 11% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

6.333

3% from 2019

SJR for Annals of the Rheumatic Diseases from 2016 - 2020
Year Value
2020 6.333
2019 6.142
2018 7.081
2017 7.699
2016 7.083
graph view Graph view
table view Table view

4.294

10% from 2019

SNIP for Annals of the Rheumatic Diseases from 2016 - 2020
Year Value
2020 4.294
2019 3.895
2018 3.725
2017 3.589
2016 3.705
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has increased by 3% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 10% in last years.
  • This journal’s SNIP is in the top 10 percentile category.
Annals of the Rheumatic Diseases

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

BMJ Publishing Group

Annals of the Rheumatic Diseases

Annals of the Rheumatic Diseases (ARD) is an international peer review journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease...... Read More

Rheumatology

Immunology and Allergy

General Biochemistry, Genetics and Molecular Biology

Medicine

i
Last updated on
08 Jun 2020
i
ISSN
0003-4967
i
Impact Factor
High - 2.815
i
Acceptance Rate
22%
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
unsrt
i
Citation Type
Numbered
[25]
i
Bibliography Example
C. W. J. Beenakker. Specular andreev reflection in graphene. Phys. Rev. Lett., 97(6):067007, 2006.

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.1136/ARD.16.4.494
Radiological Assessment of Osteo-Arthrosis

Abstract:

In a previous study (Kellgren and Bier, 1956), three sets of x rays of the hands were used to assess interand intra-observer differences in interpreting changes of rheumatoid arthritis. Wide disagreement between observers was found, and it was concluded that, to ensure maximum uniformity in grading x rays in field surveys and... In a previous study (Kellgren and Bier, 1956), three sets of x rays of the hands were used to assess interand intra-observer differences in interpreting changes of rheumatoid arthritis. Wide disagreement between observers was found, and it was concluded that, to ensure maximum uniformity in grading x rays in field surveys and therapeutic trials, all readings should be made by the same observer, preferably at a single session. The advisability of having a set of standard reference films was also considered. read more read less
View PDF
10,028 Citations
open accessOpen access Journal Article DOI: 10.1136/ARD.2010.138461
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Abstract:

Objective The 1987 American College of Rheumatology (ACR; formerly the American Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have been criticised for their lack of sensitivity in early disease. This work was undertaken to develop new classification criteria for RA. Methods A joint working grou... Objective The 1987 American College of Rheumatology (ACR; formerly the American Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have been criticised for their lack of sensitivity in early disease. This work was undertaken to develop new classification criteria for RA. Methods A joint working group from the ACR and the European League Against Rheumatism developed, in three phases, a new approach to classifying RA. The work focused on identifying, among patients newly presenting with undifferentiated inflammatory synovitis, factors that best discriminated between those who were and those who were not at high risk for persistent and/or erosive disease—this being the appropriate current paradigm underlying the disease construct ‘RA’. Results In the new criteria set, classification as ‘definite RA’ is based on the confirmed presence of synovitis in at least one joint, absence of an alternative diagnosis better explaining the synovitis, and achievement of a total score of 6 or greater (of a possible 10) from the individual scores in four domains: number and site of involved joints (range 0–5), serological abnormality (range 0–3), elevated acute-phase response (range 0–1) and symptom duration (two levels; range 0–1). Conclusion This new classification system redefines the current paradigm of RA by focusing on features at earlier stages of disease that are associated with persistent and/or erosive disease, rather than defining the disease by its late-stage features. This will refocus attention on the important need for earlier diagnosis and institution of effective disease-suppressing therapy to prevent or minimise the occurrence of the undesirable sequelae that currently comprise the paradigm underlying the disease construct ‘RA’. read more read less

Topics:

Rheumatism (52%)52% related to the paper
View PDF
5,964 Citations
open accessOpen access Journal Article DOI: 10.1136/ARD.61.6.554
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

Abstract:

Classification criteria for Sjogren's syndrome (SS) were developed and validated between 1989 and 1996 by the European Study Group on Classification Criteria for SS, and broadly accepted. These have been re-examined by consensus group members, who have introduced some modifications, more clearly defined the rules for classify... Classification criteria for Sjogren's syndrome (SS) were developed and validated between 1989 and 1996 by the European Study Group on Classification Criteria for SS, and broadly accepted. These have been re-examined by consensus group members, who have introduced some modifications, more clearly defined the rules for classifying patients with primary or secondary SS, and provided more precise exclusion criteria. read more read less

Topics:

Sicca syndrome (51%)51% related to the paper
View PDF
4,914 Citations
open accessOpen access Journal Article DOI: 10.1136/ANNRHEUMDIS-2016-210715
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

Abstract:

In this article, the 2010 European League against Rheumatism (EULAR) recommendations for the management of rheumatoid arthritis (RA) with synthetic and biological disease-modifying antirheumatic drugs (sDMARDs and bDMARDs, respectively) have been updated. The 2013 update has been developed by an international task force, whic... In this article, the 2010 European League against Rheumatism (EULAR) recommendations for the management of rheumatoid arthritis (RA) with synthetic and biological disease-modifying antirheumatic drugs (sDMARDs and bDMARDs, respectively) have been updated. The 2013 update has been developed by an international task force, which based its decisions mostly on evidence from three systematic literature reviews (one each on sDMARDs, including glucocorticoids, bDMARDs and safety aspects of DMARD therapy); treatment strategies were also covered by the searches. The evidence presented was discussed and summarised by the experts in the course of a consensus finding and voting process. Levels of evidence and grades of recommendations were derived and levels of agreement (strengths of recommendations) were determined. Fourteen recommendations were developed (instead of 15 in 2010). Some of the 2010 recommendations were deleted, and others were amended or split. The recommendations cover general aspects, such as attainment of remission or low disease activity using a treat-to-target approach, and the need for shared decision-making between rheumatologists and patients. The more specific items relate to starting DMARD therapy using a conventional sDMARD (csDMARD) strategy in combination with glucocorticoids, followed by the addition of a bDMARD or another csDMARD strategy (after stratification by presence or absence of adverse risk factors) if the treatment target is not reached within 6 months (or improvement not seen at read more read less

Topics:

Disease-modifying antirheumatic drug (55%)55% related to the paper, Antirheumatic Agents (53%)53% related to the paper, Evidence-based medicine (51%)51% related to the paper
View PDF
4,730 Citations
open accessOpen access Journal Article DOI: 10.1136/ARD.2009.108233
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

Abstract:

Objective: To validate and refine two sets of candidate criteria for the classification/diagnosis of axial spondyloarthritis (SpA). Methods: All Assessment of SpondyloArthritis international Society (ASAS) members were invited to include consecutively new patients with chronic (⩾3 months) back pain of unknown origin that bega... Objective: To validate and refine two sets of candidate criteria for the classification/diagnosis of axial spondyloarthritis (SpA). Methods: All Assessment of SpondyloArthritis international Society (ASAS) members were invited to include consecutively new patients with chronic (⩾3 months) back pain of unknown origin that began before 45 years of age. The candidate criteria were first tested in the entire cohort of 649 patients from 25 centres, and then refined in a random selection of 40% of cases and thereafter validated in the remaining 60%. Results: Upon diagnostic work-up, axial SpA was diagnosed in 60.2% of the cohort. Of these, 70% did not fulfil modified New York criteria and, therefore, were classified as having “non-radiographic” axial SpA. Refinement of the candidate criteria resulted in new ASAS classification criteria that are defined as: the presence of sacroiliitis by radiography or by magnetic resonance imaging (MRI) plus at least one SpA feature (“imaging arm”) or the presence of HLA-B27 plus at least two SpA features (“clinical arm”). The sensitivity and specificity of the entire set of the new criteria were 82.9% and 84.4%, and for the imaging arm alone 66.2% and 97.3%, respectively. The specificity of the new criteria was much better than that of the European Spondylarthropathy Study Group criteria modified for MRI (sensitivity 85.1%, specificity 65.1%) and slightly better than that of the modified Amor criteria (sensitivity 82.9, specificity 77.5%). Conclusion: The new ASAS classification criteria for axial SpA can reliably classify patients for clinical studies and may help rheumatologists in clinical practice in diagnosing axial SpA in those with chronic back pain. Trial registration number: NCT00328068. read more read less

Topics:

Juvenile Spondyloarthritis (52%)52% related to the paper
View PDF
2,704 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Annals of the Rheumatic Diseases.

It automatically formats your research paper to BMJ Publishing Group formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Annals of the Rheumatic Diseases format uses unsrt citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Annals of the Rheumatic Diseases in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Annals of the Rheumatic Diseases guidelines and auto format it.

2. Do you follow the Annals of the Rheumatic Diseases guidelines?

Yes, the template is compliant with the Annals of the Rheumatic Diseases guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Annals of the Rheumatic Diseases?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Annals of the Rheumatic Diseases citation style.

4. Can I use the Annals of the Rheumatic Diseases templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Annals of the Rheumatic Diseases.

5. Can I use a manuscript in Annals of the Rheumatic Diseases that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Annals of the Rheumatic Diseases that you can download at the end.

6. How long does it usually take you to format my papers in Annals of the Rheumatic Diseases?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Annals of the Rheumatic Diseases.

7. Where can I find the template for the Annals of the Rheumatic Diseases?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Annals of the Rheumatic Diseases's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Annals of the Rheumatic Diseases's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Annals of the Rheumatic Diseases an online tool or is there a desktop version?

SciSpace's Annals of the Rheumatic Diseases is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Annals of the Rheumatic Diseases?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Annals of the Rheumatic Diseases?”

11. What is the output that I would get after using Annals of the Rheumatic Diseases?

After writing your paper autoformatting in Annals of the Rheumatic Diseases, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Annals of the Rheumatic Diseases's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Annals of the Rheumatic Diseases?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Annals of the Rheumatic Diseases. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Annals of the Rheumatic Diseases?

The 5 most common citation types in order of usage for Annals of the Rheumatic Diseases are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Annals of the Rheumatic Diseases?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Annals of the Rheumatic Diseases's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Annals of the Rheumatic Diseases in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Annals of the Rheumatic Diseases Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Annals of the Rheumatic Diseases formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template